Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT05520567
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2022-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Sponsor:
Astellas Pharma Global Development, Inc.
Organization: